Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2272090 | 0.78 | — | — | |
| Boric Acid SCHEMBL474845 | 0.73 | THRB (0.43) | THRBALDH1A1 | |
| Boric Acid SCHEMBL4139673 | 0.73 | THRB (0.43) | THRBALDH1A1 | |
| Boric Acid SCHEMBL594481 | 0.73 | THRB (0.43) | THRBALDH1A1 | |
| Boric Acid SCHEMBL17962526 | 0.73 | THRB (0.43) | THRBALDH1A1 | |
| Boric Acid SCHEMBL4976220 | 0.73 | THRB (0.43) | THRBALDH1A1 | |
| Boric Acid SCHEMBL28285073 | 0.73 | THRB (0.43) | THRBALDH1A1 | |
| SCHEMBL10624554 | 0.73 | GGT1 (0.32) | THRBALDH1A1 | |
| Boric Acid SCHEMBL28230424 | 0.70 | THRB (0.40) | THRBALDH1A1 | |
| Boric Acid SCHEMBL28207524 | 0.70 | THRB (0.40) | THRBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9371337-B2 | β-lactamase inhibitors | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2016-06-21 | — | — | US | disclosed |
| US-20140315861-A1 | BETA-LACTAMASE INHIBITORS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-10-23 | — | — | US | disclosed |
| WO-2013056163-A1 | BETA-LACTAMASE INHIBITORS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-04-18 | — | — | WO | disclosed |
| WO-2002022137-A1 | β-LACTAM ANALOGS AND USES THEREFOR | SHOICHET BRIAN K (US) | 2002-03-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140315861-A1 | BETA-LACTAMASE INHIBITORS | BTD, GUSB, BLVRB | THRB 456/4885ALDH1A1 824/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.